Karen Moy
Medical · Dundalk, MDNPI 1154768810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 523 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 53 manufacturers, the largest accounting for just 8.7% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 523 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$853
- AbbVie$840
- AstraZeneca$778
- Pfizer$607
- Lilly USA, LLC$603
- Bayer$497
- plus $6K from 47 others
What the payments were for
- Food & beverage$9,767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,767 in reported general payments places this provider in the 90th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 133 | $101,475 |
| EliquisApixaban | 100 | $95,814 |
| OzempicSemaglutide | 52 | $78,707 |
| JardianceEmpagliflozin | 51 | $36,795 |
| FarxigaDapagliflozin Propanediol | 39 | $35,923 |
| FanaptIloperidone | 19 | $28,815 |
| XareltoRivaroxaban | 30 | $26,424 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 202 | $26,264 |
| TrulicityDulaglutide | 26 | $24,681 |
| Spiriva RespimatTiotropium Bromide | 24 | $21,583 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 77 | $21,527 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 45 | $21,448 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $18,847 |
| JanuviaSitagliptin Phosphate | 16 | $15,316 |
| EntrestoSacubitril/Valsartan | 19 | $13,257 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Incruse Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $348 | $138,283214 claims |
| PfizerEliquis | $607 | $95,814100 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $272 | $79,826120 claims |
| Novo NordiskOzempic | $853 | $78,70752 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $778 | $60,71580 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $176 | $28,81519 claims |
| Johnson & JohnsonXarelto | $157 | $26,42430 claims |
| Lilly USA, LLCTrulicity | $603 | $24,68126 claims |
| Indivior Inc.Suboxone | $301 | $21,52777 claims |
| MerckJanuvia | $93 | $15,31616 claims |
| NovartisEntresto | $59 | $13,25719 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $61 | $4,54612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 543 medical providers in Maryland.
Other medical in Dundalk
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
- Jayme WilliamsCatonsville$21K
- Megan PayneLutherville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.